Kolexia
Roth Guepin Gabrielle Hématologie
Roth Guepin Gabrielle
Hématologie
Hôpital Brabois
Vandoeuvre-lès-Nancy, France
68 Activités
90 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Maladie du greffon contre l'hôte Leucémie-lymphome lymphoblastique à précurseurs B et T Lymphomes Maladie de Hodgkin Chromosome Philadelphie Syndrome de libération de cytokines

Collaborateurs

Voir plus
Bonmati Caroline
Bonmati Caroline
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Campidelli Arnaud
Campidelli Arnaud
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Moulin Charline
Moulin Charline
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Perrot Aurore
Perrot Aurore
Oncopole Toulouse, Toulouse, France

Industries

Voir plus
Novartis
27 collaboration(s)
Dernière en 2023
Janssen
6 collaboration(s)
Dernière en 2023
BMS
2 collaboration(s)
Dernière en 2023
Amgen
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia.
Blood   07 mars 2024
Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia : A Graall Study from the Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Impact of Arsenic Trioxide in the Treatment of Higher Risk Acute Promyelocytic Leukemia
65th ASH Annual Meeting Abstracts   02 novembre 2023
Treatment-Free Remission after Ponatinib Cessation in Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients. the Ponastop Observational Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
T rial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting. Report of the First Therapeutic Sequence
65th ASH Annual Meeting Abstracts   02 novembre 2023
A new sequential conditioning regimen based on CPX- 351/Vyxeos ("Vyx-Seq") in patients with higher risk myelodysplastic syndromes.
Leukemia research   16 octobre 2023
LAMSA2020: A Phase II Randomized Study to Assess the Efficacy on Outcome of Venetoclax Combined With Cytarabine Versus Idarubicin Combined With Cytarabine Administered as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission
Essai Clinique (French Innovative Leukemia Organisation)   07 septembre 2023
Brentuximab vedotin after autoSCT in pediatric patients with R/R Hodgkin lymphoma
Youtube @ VJHemOnc – Video Journal of Hematological Oncology   28 juillet 2023
Molecular characterization of classical Hodgkin lymphoma
Youtube @ VJHemOnc – Video Journal of Hematological Oncology   26 juillet 2023
Treatment approaches, unmet needs, and ongoing research in younger patients with PMBCL
Youtube @ VJHemOnc – Video Journal of Hematological Oncology   11 juillet 2023